Delivery Order SPE2DB20D1051-SPE2DB24FD9EL
Award Date
9/6/24
Potential Completion Date
9/27/24
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,094.84, is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 7, 2024. This delivery order does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,547.42 firm fixed-price delivery order is for the supply of TABRECTA 200 MG TABLET, with a completion date of September 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and healthcare programs. This award is not...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,094.84 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,321.13 firm fixed-price delivery order contract is for the supply of TABRECTA 200 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on December 23, 2024. No set-aside designation was used for this open competition award. AmerisourceBergen...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $13,094.84. The order is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of March 21, 2024. This Delivery Order does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm fixed-price delivery order contract is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of June 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop...
This federal contract award was issued by the Department of Defense (DoD) agency, Medical Supply Chain, to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $6,547.42 firm fixed-price delivery order is for the supply of 4564654292 TABRECTA 200 MG TABLET UU 56S, with a completion date of June 11, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,094.84 firm fixed-price delivery order is for the supply of 4566306589 TABRECTA 200 MG TABLET UU 56S, with a completion date of November 25, 2024. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of TABRECTA 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $13,094.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as the...